Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R

Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R

This study examined if the Fisetin against streptozotocin-induced diabetic cardiomyopathy (DC) in rats involves regulating cardiac metabolism and suppressing protein kinase R (PKR). Male rats were divided (12/groups) as control (non-diabetic), control + Fisetin, T1DM, and T1DM + Fisetin. Fisetin was...

Full description

Bibliographic Details
Main Authors: Jozaa Z. ALTamimi, Mona N. BinMowyna, Nora A. AlFaris, Reham I. Alagal, Attalla F. El-kott, Ammar M. AL-Farga
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Saudi Pharmaceutical Journal
Subjects:
Fisetin
Diabetic cardiomyopathy
Protein Kinase R
Glucose
Rats
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016420302784

Internet

http://www.sciencedirect.com/science/article/pii/S1319016420302784

Similar Items